Condition hub
Living with polymyalgia rheumatica
What polymyalgia rheumatica does, and what its treatment does to you.
Shoulders and hips, after fifty
This aches and stiffens the shoulders and the hips, it starts after the age of fifty in almost every case, and the stiffness is worst in the morning. Getting out of bed or out of a chair is the task people describe first.
It answers to steroids within days
That fast answer is real, and it is part of how the diagnosis gets made. It also makes stopping tempting, and the illness usually comes back when the drug stops too soon, which is why the step-down is slow and belongs to whoever prescribes it.
Giant cell arteritis is tied to it
A new headache, jaw pain when chewing, a tender scalp or any change in vision needs seeing the same day. Blood tests do not settle it either way, and close to one patient in six with the diagnosis had both inflammatory markers completely normal in one series.4
A long steroid course reaches past bone
Bone is the most predictable worry and the guideline covers it directly. Blood sugar, blood pressure, weight, mood, sleep and how easily you catch things are all affected too, and not one of them is the price of feeling better.1
The four-step plan, applied to polymyalgia rheumatica.
Get the right diagnosis
The pattern of the stiffness, your age, the inflammatory markers, and how quickly you answer to treatment. Ask about headache, jaw and vision symptoms at every visit, because giant cell arteritis is the one that cannot wait.
Polymyalgia rheumatica and labs →Clean up your food
No diet trial has been run in this illness at all, so any diet sold for it has cleared no bar. Calcium and vitamin D are the exception, because the steroid guideline asks for both.
Polymyalgia rheumatica and diet →Detox your daily life
Smoking, workplace exposure and air pollution have never been measured in this illness. What has been measured is what a long steroid course does, which is the exposure with the most behind it here.
Polymyalgia rheumatica and environment →Build a stronger body
The steroid guideline calls for weight-bearing and strength-building work, and that is the sourced instruction here. Steroids take muscle while you are on them, so the work is protecting what you have.
Polymyalgia rheumatica and exercise →
Pro tip
Ask at your first appointment who is keeping an eye on your bones. Bone care belongs in the conversation at the start of a long steroid course and not after a fracture, and what the guideline advises depends on your own risk of a break instead of being one rule for everybody.
The answer to treatment, which helps make the diagnosis
Steroids and bone
Treatment means steroids for a long stretch, so what those drugs do becomes part of what has to be managed, and bone is the most predictable worry of the lot. The guideline splits people into two groups by their own risk of a break. Adults at low risk should get calcium and vitamin D, and adults at middle or high risk should get those two plus a bone drug.
Long steroid courses touch a good deal more than bone. Blood sugar, blood pressure, weight, mood, sleep, and how easily you catch things are all affected, and those are worth raising as they come up. Not one of them is the price of feeling better, several can be managed, and poor sleep and mood changes in particular tend to go unsaid.
Vitamin D, and what one study found
Common misconceptions.
Myth. PMR is the same as rheumatoid arthritis.
Reality. They're very different. PMR affects the shoulder and hip girdle (proximal), not the small joints. Anti-CCP and RF are negative. The treatment is different (low-dose prednisone for PMR, DMARDs and biologics for RA). And PMR can co-occur with GCA, a feature RA doesn't have.
In plain words. PMR and RA are two different illnesses. PMR hits the shoulders and hips, not the small joints. The RA blood tests come back negative, and the drugs are different too. PMR can come with giant cell arteritis, which RA doesn't.
When to see a rheumatologist.
See a rheumatologist if you have:
- Bilateral shoulder and hip girdle pain and stiffness lasting more than 2 weeks
- Morning stiffness lasting more than 45 minutes
- Age over 50 (PMR is rare before 50)
- Elevated ESR or CRP on a routine lab
- Difficulty getting out of bed or out of a chair due to stiffness
- Any new headache, vision change, or jaw claudication (GCA red flag, urgent)
A new headache, jaw pain when chewing, or any change in vision in somebody with this diagnosis is a same-day problem, because giant cell arteritis can take sight for good. Everything else on this list is a prompt appointment, and normal blood tests do not rule the urgent one out.
References.
- Buckley L; Guyatt G; Fink H et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis. Arthritis & Rheumatology. 2017;69:1521-1537. 10.1002/art.40137GRADE-based clinical practice guideline
- Hysa E; Balito S; Davoli G et al. Vitamin D Status and Response to Supplementation as Predictive Factors for Early Remission in Polymyalgia Rheumatica: A Retrospective Longitudinal Investigation. Nutrients. 2025;17:2839. 10.3390/nu17172839Retrospective observational case-control study with a longitudinal subgroup
- Palmowski A; Wiebe E; Muche B et al. Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides—Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort. Cells. 2022;11:536. 10.3390/cells11030536Cross-sectional baseline analysis of a prospective cohort
- Currier C; Bays A; Thomason J. Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot. Rheumatology International. 2025;45. 10.1007/s00296-025-05930-3Retrospective diagnostic accuracy study within a single fast-track GCA clinic
- Dejaco C; Singh Y; Perel P et al. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Annals of the Rheumatic Diseases. 2015;74:1799-1807. 10.1136/annrheumdis-2015-207492International guideline
This page gathers the published research on this subject into one place. The studies behind it were published between 1989 and 2026, and every figure links to the paper it came from. Those studies were peer reviewed. This summary of them was not. Dr. Sarah Luebker is reviewing these pages one at a time and has not reached this one yet, so it carries no medical review date and nothing here is her opinion or her advice to you. Each page gets updated as she reaches it. It is here in the meantime because the science is worth having in one organized place that is easy to find and easy to read. Talk to your own clinician before acting on any of it.